Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
Company Details
- Employees
- 17
- Address
- One Kendall Square, Building 200
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://passkeytx.com/
- HQ
- Cambridge, MA
Passkey Therapeutics Questions
Passkey Therapeutics's website is https://passkeytx.com/
Passkey Therapeutics's LinkedIn profile is https://www.linkedin.com/company/passkey-therapeutics
Passkey Therapeutics has
17 employees.
View email and phone details for 17
employees at Passkey Therapeutics.
Passkey Therapeutics's industry is
Biotechnology Research
Passkey Therapeutics's top competitors are
Avencell,
Enveda,
Seaport Therapeutics,
Be Biopharma,
Triveni Bio,
Breakout Ventures,
Judo Bio,
Dyno Therapeutics,
Atavistik Bio,
Dewpoint Therapeutics.
Passkey Therapeutics's categories are Biotechnology Research
